The main aim of the study is to describe plasma pharmacokinetics (PK) and pulmonary diffusion of high-dose ceftobiprole (500 mg loading dose followed by 2.5 g under continuous infusion for 24h) for mechanically-ventilated adult patients with severe community-acquired pneumonia, using population PK modelling. The secondary aims are : A- To determine whether the pharmacokinetic / pharmacodynamic (PK/PD) targets can be achieved in the plasma and epithelial lining fluid with the recommended doses of ceftobiprole. B- To define the optimal dose regimen for ceftobiprole in this population. C- To evaluate clinical recovery (at Day 3 and Day 8) and microbiological recovery (at Day 3). D- To evaluate the clinical evolution. E- To evaluate the clinical and biological tolerance.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Plasma concentration of ceftobiprole on Day 1
Timeframe: Day 1
Blood test after injection of loading-dose Ceftobiprole (Cmax) for 30 minutes
Timeframe: Day 1 (after the 30-minute injection)
Blood test 2 hours AFTER beginning antibiotic therapy with ceftobiprole
Timeframe: Day 1, 2 hours from start of treatment
Blood test 6 hours AFTER beginning antibiotic therapy with ceftobiprole
Timeframe: Day 1, 6 hours from start of treatment
Blood test 8 hours AFTER beginning antibiotic therapy with ceftobiprole
Timeframe: Day 1, 8 hours from start of treatment
Blood test 12 hours AFTER beginning antibiotic therapy with ceftobiprole
Timeframe: Day 1, 12 hours from start of treatment
Time 2 blood test on third day of antibiotic therapy with ceftobiprole
Timeframe: Day 3 at Time 2
Time 6 blood test on third day of antibiotic therapy with ceftobiprole
Timeframe: Day 3 at Time 6
Time 8 blood test on third day of antibiotic therapy with ceftobiprole
Timeframe: Day 3 at Time 8
Time 12 blood test on third day of antibiotic therapy with ceftobiprole
Timeframe: Day 3 at Time 12